HomeLENZ • NASDAQ
add
Lenz Therapeutics Inc
Previous close
$15.45
Day range
$15.05 - $16.00
Year range
$15.05 - $24.59
Market cap
401.40M USD
Avg Volume
108.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 24.99M | 173.79% |
Net income | -23.69M | -151.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -24.98M | -173.84% |
Effective tax rate | 0.75% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 65.79M | 48.05% |
Total assets | 70.38M | 49.89% |
Total liabilities | 18.83M | 93.85% |
Total equity | 51.55M | — |
Shares outstanding | 25.53M | — |
Price to book | -1.73 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -23.69M | -151.27% |
Cash from operations | -20.97M | -180.99% |
Cash from investing | 15.17M | 505,866.67% |
Cash from financing | -1.91M | -109.43% |
Net change in cash | -7.71M | -160.27% |
Free cash flow | — | — |
About
Founded
2020
Headquarters
Website
Employees
6